© 2019 by Phenocell SAS - Photo credit : Kim Garell, F. Simonnet and the Phenocell Team


Improve the

relevance of your


Ingredient qualification made easy thanks to innovative in vitro  assays with human cells derived from iPSC

Unlimited availability of cells with standardized batches

Improved reproducibility 

Choice of ethnic skin cells from caucasian, asian

or african origin

Strong confidentiality and intellectual property protection.

A highly qualified team of researchers and engineers, here to help accelerating your R&D programs.

Why iPSC ?

Induced pluripotent stem cells (iPSC) are cells with the characteristics of embryonic stem cells, generated from an adult cell.

iPSC possess the ability to self-renew, or multiply identically in vitro. They also retain the ability to form any cell type of the Human body, a property called pluripotency.

Self-renewal, or unlimited expansion, allows generating billions of cells nearly identical to perform long-term studies. Pluripotency affords the possibility to obtain all cellular models needed to study a single pathophysiological situation.

IPSC are unique tools for pathophysiological modeling and compound assessment. They are used worldwide by more than 2000 research teams, in academia and the pharmaceutical and cosmetic industry.

Why Phenocell ?

Phenocell has acquired a premium expertise in human iPSC production (more than 180 iPSC lines created to date from normal and pathological background) and had developed robust processes to differentiate iPSC into somatic cells.


Our offer of skin cells (sebocytes, melanocytes and keratinocytes) from a variety of ethnic backgrounds is unique worldwide.

Each cell type comes with a panel of bioassays to target the main functions and dysfunction of human tissues.